Search

everythinglearnresearchcommunity

for

Search:↓

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

COVID-19 affects patients on chemotherapy for gynecological cancer negatively.

YH0618 helped reduce skin and nail problems and fatigue in chemotherapy patients.

CAP7.1 is generally safe at 200 mg/m²/day, but can cause fatigue, nausea, hair loss, fever, and blood-related issues.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

CHOP chemotherapy causes many side effects but is generally well tolerated.

CVP therapy showed moderate success in treating advanced non-Hodgkin's lymphoma, but more intensive treatment is needed for better outcomes.

Scalp cooling may be less effective for women of color on certain chemotherapy treatments.

Adriamycin and ifosfamide together work best for advanced soft tissue sarcomas.

Mononuclear cells may protect against certain chemotherapy-induced hair loss.

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.

Chemotherapy reduces splenic melanin in mice.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

The treatment was effective for advanced non-Hodgkin's lymphomas.

The treatment is safe and shows promise for metastatic breast cancer.

Chemotherapy causes hair loss, nausea, fatigue, and blood issues, but counseling can help manage these effects.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

Nurses are exposed to chemotherapy drugs, risking health issues like hair loss, so protective gear and monitoring are needed.

High-dose intravenous iron therapy doesn't interfere with treatment improvements in IBD patients with iron deficiency anemia.

Scalp cooling effectively prevents chemotherapy-induced hair loss but requires better pain management.

Suppressing eIF4E can prevent hair loss from chemotherapy.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

Busulfan/cyclophosphamide and total bone irradiation are equally effective for AML transplants.

Personalized treatment and teamwork among doctors can reduce chemotherapy side effects and improve patient outcomes.

A scalp-cooling system effectively prevents hair loss in breast cancer patients treated with eribulin.

Intralesional chemotherapy with 5-fluorouracil and methotrexate may worsen keratoacanthoma-type skin cancer in transplant patients.

Early detection of chemotherapy side effects allows treatment adjustments, improving patient outcomes.